Most interestingly, we identified two MALAT1-dependent novel molecules, ZNF638 and SENP8, that are associated with significant alterations in colon adenocarcinoma patients’ overall survival and disease-free survival. Here, ZNF638 is linked to colon adenocarcinoma.